- Home
- NRXP vs MTNB Comparison
NRXP vs MTNB Comparison
Compare NRXP & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- MTNB
- Stock Information
- Founded
- NRXP 2015
- MTNB 2013
- Country
- NRXP United States
- MTNB United States
- Employees
- NRXP N/A
- MTNB N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- NRXP Health Care
- MTNB Health Care
- Exchange
- NRXP Nasdaq
- MTNB Nasdaq
- Market Cap
- NRXP 32.6M
- MTNB 3.6M
- IPO Year
- NRXP N/A
- MTNB N/A
- Fundamental
- Price
- NRXP $3.24
- MTNB $1.00
- Analyst Decision
- NRXP Strong Buy
- MTNB Hold
- Analyst Count
- NRXP 4
- MTNB 1
- Target Price
- NRXP $28.50
- MTNB N/A
- AVG Volume (30 Days)
- NRXP 204.8K
- MTNB 354.9K
- Earning Date
- NRXP 08-13-2025
- MTNB 08-13-2025
- Dividend Yield
- NRXP N/A
- MTNB N/A
- EPS Growth
- NRXP N/A
- MTNB N/A
- EPS
- NRXP N/A
- MTNB N/A
- Revenue
- NRXP N/A
- MTNB N/A
- Revenue This Year
- NRXP N/A
- MTNB N/A
- Revenue Next Year
- NRXP N/A
- MTNB N/A
- P/E Ratio
- NRXP N/A
- MTNB N/A
- Revenue Growth
- NRXP N/A
- MTNB N/A
- 52 Week Low
- NRXP $1.10
- MTNB $0.47
- 52 Week High
- NRXP $6.01
- MTNB $9.60
- Technical
- Relative Strength Index (RSI)
- NRXP 53.62
- MTNB 63.74
- Support Level
- NRXP $2.90
- MTNB $0.88
- Resistance Level
- NRXP $3.53
- MTNB $1.05
- Average True Range (ATR)
- NRXP 0.20
- MTNB 0.07
- MACD
- NRXP -0.04
- MTNB 0.00
- Stochastic Oscillator
- NRXP 58.73
- MTNB 86.34
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.